British Columbia Investment Management Trimmed By $1.90 Million Its Illumina (ILMN) Holding; Ventas (VTR) SI Decreased By 3.76%

Ventas, Inc. (NYSE:VTR) Logo

British Columbia Investment Management Corp decreased Illumina Inc (ILMN) stake by 9.04% reported in 2018Q3 SEC filing. British Columbia Investment Management Corp sold 5,184 shares as Illumina Inc (ILMN)’s stock declined 7.53%. The British Columbia Investment Management Corp holds 52,130 shares with $19.14M value, down from 57,314 last quarter. Illumina Inc now has $43.15 billion valuation. The stock increased 0.45% or $1.32 during the last trading session, reaching $293.52. About 788,778 shares traded. Illumina, Inc. (NASDAQ:ILMN) has risen 50.49% since February 13, 2018 and is uptrending. It has outperformed by 50.49% the S&P500. Some Historical ILMN News: 09/05/2018 – CareDx expands NGS Transplant Product Offerings; 08/05/2018 – CAREDX-AGREEMENT PROVIDES CO WITH WORLDWIDE DISTRIBUTION, DEVELOPMENT, COMMERCIALIZATION RIGHTS TO ILLUMINA’S TRANSPLANT CLINICAL APPLICATION PRODUCTS; 10/04/2018 – ILLUMINA INC – LOXO ONCOLOGY TO UTILIZE A COMPANION DIAGNOSTIC VERSION OF TRUSIGHT TUMOR 170 FOR LAROTRECTINIB (NTRK) AND LOXO-292 (RET); 24/04/2018 – ILLUMINA INC – FOR FISCAL 2018, COMPANY NOW PROJECTS GAAP EARNINGS PER DILUTED SHARE ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS OF $4.45 TO $4.55; 22/03/2018 – The Shuman Law Firm Investigates Illumina, Inc; 10/04/2018 – Loxo and Illumina in partnership over diagnostic for cancer drug; 02/05/2018 – Illumina Presenting at Bank of America Conference May 16; 10/04/2018 – Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics; 24/04/2018 – Illumina Sees FY18 Adj EPS $4.75-Adj EPS $4.85; 13/04/2018 – BRISTOL-MYERS SQUIBB CO – EXPANDS ILLUMINA’S ONCOLOGY OFFERINGS FOR NEXTSEQ 550DX

Ventas Inc (NYSE:VTR) had a decrease of 3.76% in short interest. VTR’s SI was 7.24M shares in February as released by FINRA. Its down 3.76% from 7.52 million shares previously. With 2.01M avg volume, 4 days are for Ventas Inc (NYSE:VTR)’s short sellers to cover VTR’s short positions. The SI to Ventas Inc’s float is 2.04%. The stock increased 1.23% or $0.78 during the last trading session, reaching $64.22. About 1.60 million shares traded. Ventas, Inc. (NYSE:VTR) has risen 1.98% since February 13, 2018 and is uptrending. It has outperformed by 1.98% the S&P500. Some Historical VTR News: 27/04/2018 – Ventas Sees 2018 Normalized FFO $3.99-$4.07/Share; 27/04/2018 – Land & Buildings Comments on Brookdale and Ventas Announcements; 27/04/2018 – Ventas to Pursue Sale of Brookdale Portfolio Properties Totaling Up to $30 Million in Cash Rent; 16/05/2018 – Ventas Board Reappoints Debra Cafaro as Chairman; 19/03/2018 – Cramer’s lightning round: I know people worry about Ventas, but I’m not backing down; 27/04/2018 – Ventas Raises 2018 Normalized FFO View; 27/04/2018 – VENTAS INC QTRLY REPORTED FFO PER DILUTED COMMON SHARE WAS $0.96; 16/05/2018 – Ventas Board Reappoints James Shelton as Presiding Director to Lead Executive Sessions; 16/05/2018 – Ventas Declares Regular Quarterly Dividend of $0.79 Per Share; 30/05/2018 – MOODY’S ASSIGNS B3 CFR TO AHP HEALTH PARTNERS; OUTLOOK STABLE

Among 4 analysts covering Illumina (NASDAQ:ILMN), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Illumina had 4 analyst reports since October 24, 2018 according to SRatingsIntel. As per Thursday, January 3, the company rating was upgraded by UBS. The firm earned “Equal-Weight” rating on Monday, January 7 by Morgan Stanley. The stock of Illumina, Inc. (NASDAQ:ILMN) earned “Overweight” rating by Barclays Capital on Wednesday, October 24. Deutsche Bank downgraded Illumina, Inc. (NASDAQ:ILMN) on Friday, January 25 to “Hold” rating.

More notable recent Illumina, Inc. (NASDAQ:ILMN) news were published by: which released: “Here is Why Growth Investors Should Buy Illumina (ILMN) Now – Nasdaq” on January 18, 2019, also with their article: “CBM or ILMN: Which Is the Better Value Stock Right Now? – Nasdaq” published on January 31, 2019, published: “Illumina (ILMN) Q4 Earnings Lag Estimates, Revenues Top Mark – Nasdaq” on January 30, 2019. More interesting news about Illumina, Inc. (NASDAQ:ILMN) were released by: and their article: “Illumina Q4 2018 Earnings Preview – Seeking Alpha” published on January 28, 2019 as well as‘s news article titled: “Can Solid Consumables Drive Illumina’s (ILMN) Q4 Earnings? – Nasdaq” with publication date: January 24, 2019.

Since September 4, 2018, it had 0 buys, and 36 insider sales for $30.52 million activity. The insider FLATLEY JAY T sold $1.06M. EPSTEIN ROBERT S also sold $496,876 worth of Illumina, Inc. (NASDAQ:ILMN) shares. $194,461 worth of Illumina, Inc. (NASDAQ:ILMN) was sold by Dadswell Charles. On Wednesday, January 2 the insider deSouza Francis A sold $879,994. 5,000 shares valued at $1.47 million were sold by EASTHAM KARIN on Tuesday, November 6. Van Oene Mark sold 1,091 shares worth $386,410. 10,000 Illumina, Inc. (NASDAQ:ILMN) shares with value of $3.47 million were sold by Ronaghi Mostafa.

British Columbia Investment Management Corp increased Hershey Co (NYSE:HSY) stake by 7,638 shares to 50,444 valued at $5.15 million in 2018Q3. It also upped Fluor Corp New (NYSE:FLR) stake by 85,812 shares and now owns 127,751 shares. Westlake Chem Corp (NYSE:WLK) was raised too.

Investors sentiment decreased to 1.33 in 2018 Q3. Its down 0.20, from 1.53 in 2018Q2. It worsened, as 35 investors sold ILMN shares while 207 reduced holdings. 119 funds opened positions while 202 raised stakes. 126.72 million shares or 1.43% less from 128.56 million shares in 2018Q2 were reported. Fmr Ltd Liability owns 559,365 shares or 0.02% of their US portfolio. 234,527 were reported by California State Teachers Retirement. Geode Cap Mngmt Lc holds 0.17% or 1.68 million shares. Profund Ltd Liability Company accumulated 61,782 shares. Maryland-based Chevy Chase Trust Hldgs has invested 0.67% in Illumina, Inc. (NASDAQ:ILMN). Wetherby Asset Mgmt Inc holds 0.1% of its portfolio in Illumina, Inc. (NASDAQ:ILMN) for 2,259 shares. Northwestern Mutual Wealth Mgmt invested 0% in Illumina, Inc. (NASDAQ:ILMN). Kepos Cap Limited Partnership reported 12,037 shares. Citigroup stated it has 88,593 shares. Royal London Asset Mngmt holds 0% of its portfolio in Illumina, Inc. (NASDAQ:ILMN) for 89,727 shares. C M Bidwell Limited has invested 0.72% of its portfolio in Illumina, Inc. (NASDAQ:ILMN). Oppenheimer & Communication invested in 0.85% or 91,122 shares. Comerica Bancshares reported 32,415 shares stake. Schwab Charles Invest Mngmt Incorporated stated it has 601,728 shares or 0.15% of all its holdings. Wilbanks Smith And Thomas Asset Limited Liability Company invested in 104 shares.

Among 4 analysts covering Ventas (NYSE:VTR), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Ventas had 4 analyst reports since October 30, 2018 according to SRatingsIntel. The firm earned “Sector Perform” rating on Friday, November 2 by RBC Capital Markets. The firm has “Market Perform” rating by BMO Capital Markets given on Monday, February 11.

Since August 31, 2018, it had 0 buys, and 5 selling transactions for $4.08 million activity. On Thursday, December 6 the insider Cobb John D. sold $650,000. 15,676 Ventas, Inc. (NYSE:VTR) shares with value of $1.02M were sold by RINEY T RICHARD. The insider Probst Robert F sold $633,096.

Ventas, Inc. is a publicly owned real estate investment trust. The company has market cap of $23.08 billion. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It has a 56.33 P/E ratio. It invests in the real estate markets of the United States and Canada.

Ventas, Inc. (NYSE:VTR) Institutional Positions Chart